SynthesisFrontiers in oncology2025

First-line immunochemotherapy for advanced NSCLC in Asian patients: a meta-analysis of phase 3 RCTs.

Zhifang Mao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.